Melanoma Research Victoria

Source: Medical Express, July 2019 (HealthDay)—Patients with multiple primary melanomas have worse overall survival than those with a single primary melanoma, according to a study published online June 26 in JAMA Dermatology. Mary-Ann El Sharouni, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues described the epidemiologic features of multiple primary melanoma in a retrospective […]

Read the full story

Source: Healthcare IT, July 2019 Computational biology has enabled researchers at the Walter and Eliza Hall Institute to develop a new method to identify melanoma patients. A new study also highlights the role computational biology could play in furthering understanding of cancer biology and patient outcomes in the future. The method outlined in the research […]

Read the full story

Journal of Cancer Survivorship The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors Julia Lai-Kwon, Chloe Khoo, Serigne Lo, Donna Milne, Mustafa Mohamed, Jeanette Raleigh, Kortnye Smith, Karolina Lisy, Shahneen Sandhu, Michael Jefford Original Research First Online: 04 June 2019 (https://doi.org/10.1007/s11764-019-00770-0) The lancet Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial […]

Read the full story

Source: ScienceDaily, July 2019 Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden’s most common forms of cancer. A research team at Lund University in Sweden has studied a protein […]

Read the full story